Advertisement

Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms

0

Two phase 3 trials showed that elinzanetant reduced VMS frequency and improved VMS severity at weeks 4 and 12

Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price

0
By Ernie Mundell HealthDay Reporter TUESDAY, Aug. 27, 2024 (HealthDay News) -- Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says...

WHO Unveils Plan to End African Mpox Outbreak

0
By Robin Foster HealthDay Reporter TUESDAY, Aug. 27, 2024 (HealthDay News) -- As an mpox outbreak continues to rage in Africa, the World Health Organization...

Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care Providers

0

Nearly half of U.S. counties have at least one community with a pharmacy desert

Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time

0

High-intensity adopters had reduction in documentation for full postadoption periods and following learning period

FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type...

0

Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks

Meat Consumption Linked to Increased Incidence of Type 2 Diabetes

0

Risk increased in association with consumption of 100 g/day red meat, 50 g/day processed meat

Digital Cognitive Behavioral Therapy App Aids Anxiety

0

Engagement and quality ratings were similar across incentive conditions

1999 to 2023 Saw Increase in Heat-Related Mortality Rates

0

Number of heat-related deaths and age-adjusted mortality rate increased for heat-related deaths

Most Americans Unprepared to Handle Opioid Overdoses

0

Overdose deaths have increased fourfold during the past two decades in the United States